Get started
Author

Anton Burkhard‐Meier

Observed names: A. Burkhard-Meier, Anton Burkhard-Meier, Anton Burkhard–Meier, Burkhard-Meier, Anton
ORCID: 0009-0002-9801-3530
Observed ORCID: 0009-0002-9801-3530
OpenAlex ID: A5022356274
First-line pazopanib in patients with metastatic epithelioid hemangioendothelioma: a retrospective single-center analysis
2025 · Anton Burkhard-Meier, Vera Valerie Rechenauer, et al. · Journal of Cancer Research and Clinical Oncology · 9
PDF
Sapovirus: an emerging pathogen in kidney transplant recipients?
2024 · Michaela Rippl, Anton Burkhard-Meier, et al. · Infection · 9
PDF
Implementing precision oncology for sarcoma patients: the CCCLMUmolecular tumor board experience
2023 · Luc M. Berclaz, Anton Burkhard-Meier, et al. · Journal of Cancer Research and Clinical Oncology · 9
PDF
Unraveling the role of local ablative therapies for patients with metastatic soft tissue sarcoma – A retrospective multicenter study of the Bavarian university hospitals
2024 · Anton Burkhard-Meier, Matthias Grube, et al. · European Journal of Surgical Oncology · 8
PDF
Differentiation of benign and metastatic lymph nodes in soft tissue sarcoma
2024 · Anton Burkhard-Meier, Vindi Jurinovic, et al. · Clinical & Experimental Metastasis · 7
PDF
Does Size Outweigh Number in Predicting Survival After Pulmonary Metastasectomy for Soft Tissue Sarcoma? Insights from a Retrospective Multicenter Study
2025 · Anton Burkhard-Meier, Matthias Grube, et al. · Annals of Surgical Oncology · 6
PDF
LDH and hemoglobin outperform systemic inflammatory indices as prognostic factors in patients with soft tissue sarcoma undergoing neoadjuvant treatment
2025 · Luc M. Berclaz, Dorit Di Gioia, et al. · BMC Cancer · 6
TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS)
2023 · Luc M. Berclaz, Annelore Altendorf-Hofmann, et al. · Cancers · 6
PDF
Treatment of metastatic alveolar soft part sarcoma with axitinib and pembrolizumab in an 80-year-old patient with a history of autoimmune disorders
2022 · Klara Dorman, Anton Burkhard-Meier, et al. · Anti-Cancer Drugs · 6
Primary cardiac sarcoma: insights from two decades of multimodal management at LMU Munich
2025 · Anton Burkhard-Meier, Dorit Di Gioia, et al. · Cardio-Oncology · 3
PDF
Durable response to nivolumab in combination with regional hyperthermia in a patient with PD-L1-negative metastatic head and neck squamous cell carcinoma
2025 · Luc M. Berclaz, Anton Burkhard-Meier, et al. · Cancer Immunology Immunotherapy · 3
PDF
The impact of CT-based adipose tissue distribution and sarcopenia on treatment outcomes in patients with high-risk soft tissue sarcoma
2025 · Luc M. Berclaz, Dorit Di Gioia, et al. · BMC Cancer · 3
PDF
Doxorubicin Plus Dacarbazine Versus Doxorubicin Plus Ifosfamide in Combination With Regional Hyperthermia in Patients With Advanced Leiomyosarcoma: A Propensity Score‐Matched Analysis
2025 · Luc M. Berclaz, Vindi Jurinovic, et al. · Cancer Medicine · 3
PDF
Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: a machine learning analysis
2026 · Michael Hoberger, Romy L. Zuber, et al. · Journal of Cancer Research and Clinical Oncology · 1
PDF
2728P Initial clinical data confirm galenic principle and demonstrate therapeutic potential of THE001 (DPPG2-TSL-DOX) combined with regional hyperthermia (RHT) in soft tissue sarcoma (STS)
2025 · D. Di Gioia, P. Reichardt, et al. · Annals of Oncology · 1
Surgery for Retroperitoneal Soft Tissue Sarcoma is Safe Following Multimodal Treatment with Regional Hyperthermia
2025 · Mathilda Knoblauch, Cathy Werdel, et al. · Annals of Surgical Oncology · 1
PDF
Maintenance treatment with trofosfamide in patients with advanced soft tissue sarcoma – a retrospective single-centre analysis
2025 · Anton Burkhard-Meier, Vera Valerie Rechenauer, et al. · Acta Oncologica · 1
PDF
Neues zu Weichteilsarkomen
2024 · Anton Burkhard-Meier, Luc M. Berclaz, et al. · DMW - Deutsche Medizinische Wochenschrift · 1
Matched primary-metastasis single-nucleus and spatial profiling of leiomyosarcoma identifies antigen-presenting fibroblasts at the tumor-organ interface
2026 · Anna Kübler, Linda Bergmayr, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
ASCO 2026: Weichgewebe- und Knochensarkome Zielgerichtete Therapien etablieren sich bei seltenen Tumoren
2026 · Luc M. Berclaz, Anton Burkhard-Meier, et al. · Trillium Krebsmedizin
Machine Learning-Guided Survival Prediction and Treatment Sequencing in Advanced Soft Tissue Sarcoma Beyond Second-Line Therapy: A Retrospective Cohort Study
2026 · Michael Hoberger, Dorit Di Gioia, et al. · Oncology and Therapy
PDF
Correction: Surgery for Retroperitoneal Soft Tissue Sarcoma is Safe Following Multimodal Treatment with Regional Hyperthermia
2025 · Mathilda Knoblauch, Cathy Werdel, et al. · Annals of Surgical Oncology
PDF
ASO Visual Abstract: Surgery for Retroperitoneal Soft Tissue Sarcoma is Safe Following Multimodal Treatment with Regional Hyperthermia
2025 · Mathilda Knoblauch, Cathy Werdel, et al. · Annals of Surgical Oncology
PDF
Combination of the Dual Pan-PI3K/PIM Inhibitor Ibl-202 with the BCL-2 Inhibitor Venetoclax Enhances Apoptotic Priming and Is an Effective Targeted Treatment Approach in Mantle Cell Lymphoma
2024 · Anton Gaiderov, Anton Burkhard-Meier, et al. · Blood
Neues zu Weichteilsarkomen
2024 · Anton Burkhard-Meier, Luc M. Berclaz, et al. · TumorDiagnostik & Therapie
Works count: 34
Citation count: 83
H-index: 6
I10-index:
Year
Topic
Type